Holen Sie sich die Stockscreener-App
5.54
6.13%
0.32
Schlusskurs vom Vortag:
$5.22
Offen:
$5.31
24-Stunden-Volumen:
722.27K
Relative Volume:
0.27
Marktkapitalisierung:
$630.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-236.60M
KGV:
-2.0671
EPS:
-2.6801
Netto-Cashflow:
$-161.34M
1W Leistung:
-5.78%
1M Leistung:
-25.54%
6M Leistung:
-2.12%
1J Leistung:
+80.46%
1-Tages-Spanne:
$5.31
$5.605
1-Wochen-Bereich:
$4.88
$5.87
52-Wochen-Spanne:
$2.25
$8.90
Compass Pathways Plc Adr Stock (CMPS) Company Profile
Firmenname
Compass Pathways Plc Adr
Sektor
Branche
Telefon
1-716-676-6461
Adresse
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
Compare CMPS vs HCA, THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CMPS
Compass Pathways Plc Adr
|
5.5499 | 592.56M | 0 | -236.60M | -161.34M | -2.6801 |
HCA
Hca Healthcare Inc
|
481.70 | 108.59B | 75.60B | 7.78B | 7.69B | 28.38 |
THC
Tenet Healthcare Corp
|
198.24 | 17.36B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
22.10 | 12.31B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
203.68 | 11.79B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
184.41 | 11.36B | 17.36B | 1.51B | 849.25M | 23.15 |
Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-23 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-02-27 | Eingeleitet | Stifel | Buy |
| 2024-07-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-04-01 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2022-11-21 | Fortgesetzt | Berenberg | Buy |
| 2022-11-01 | Eingeleitet | Loop Capital | Buy |
| 2021-10-29 | Eingeleitet | Oppenheimer | Outperform |
| 2021-07-13 | Eingeleitet | Citigroup | Buy |
| 2021-06-28 | Eingeleitet | Maxim Group | Buy |
| 2021-05-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-01 | Eingeleitet | ROTH Capital | Buy |
| 2020-10-14 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-10-13 | Eingeleitet | Berenberg | Buy |
| 2020-10-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-10-13 | Eingeleitet | Cowen | Outperform |
| 2020-10-13 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Compass Pathways Plc Adr Aktie (CMPS) Neueste Nachrichten
Compass Pathways (NASDAQ: CMPS) posts pivotal TRD wins and targets 2026 NDA - Stock Titan
Compass Pathways Eyes Rolling FDA Filing for COMP360, Preps TRD Launch Ahead of Q3 Data - Yahoo Finance
Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Short Interest Update - MarketBeat
Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Compass Pathways to Present at Stifel 2026 Virtual CNS Forum on March 18, 2026 - Barchart.com
Compass Pathways (NASDAQ:CMPS) Trading Down 6.3%What's Next? - MarketBeat
Compass Pathways (NASDAQ:CMPS) Trading 8.8% HigherWhat's Next? - MarketBeat
Jefferies Financial Group Inc. Invests $7.89 Million in Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat
CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions - Sahm
Compass Pathways Highlights Phase 3 COMP360 TRD Gains, 26-Week Durability and FDA Path at Conference - Yahoo Finance
Why Did Compass Pathways Stock Rocket Higher Today? - AOL.com
Blue Owl Capital Holdings LP Acquires 375,000 Shares of Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat
HC Wainwright Has Positive Outlook of CMPS FY2026 Earnings - Defense World
HC Wainwright Lifts Earnings Estimates for Compass Pathways - MarketBeat
Propel Bio Management LLC Makes New $2.92 Million Investment in Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat
ARK Investment Management LLC Buys 471,897 Shares of Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat
FY2030 Earnings Forecast for CMPS Issued By HC Wainwright - MarketBeat
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders - Benzinga
Compass Pathways raises $200M from warrant exercises - Investing.com
Compass Pathways (NASDAQ:CMPS) Stock Price Down 6.9%Here's Why - MarketBeat
Sonoco Products posts upbeat Q4 earnings, joins Compass Pathways, Masimo, Itron and other big stocks moving higher on Tuesday - MSN
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year? - Bitget
Magic Mushrooms, Hard Cash: Compass Pathways’ Trial Win, Fast Raise - MarketBeat
Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise - Finviz
Cathie Wood’s ARK sells DraftKings stock, buys Figma and Compass Pathways - Investing.com South Africa
Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model Updates - Finviz
Compass Pathways prices $150 million public offering of ADSs By Investing.com - Investing.com South Africa
Compass Pathways prices $150 million public offering of ADSs - Investing.com
Compass Pathways announces $150 million ADS offering - Investing.com India
Rezolve AI PLC (NASDAQ:RZLV) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Mister Car Wash, Inc. (NYSE:MCW) Given Consensus Rating of “Hold” by Analysts - Defense World
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Compass Pathways announces $150 million ADS offering By Investing.com - Investing.com UK
COMPASS Pathways touts Phase III psilocybin wins in TRD, eyes FDA NDA and expedited review - Yahoo Finance
Sonoco Products Posts Upbeat Q4 Earnings, Joins Compass Pathways, Masimo, Itron And Other Big Stocks Moving Higher On Tuesday - Benzinga
Compass Pathways stock soars after positive Phase 3 trial results By Investing.com - Investing.com India
Compass Pathways stock soars after positive Phase 3 trial results - Investing.com
Compass Pathways reports positive phase 3 results for depression drug - Investing.com
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Short Interest Update - Defense World
Compass Pathways to release new clinical data on psilocybin trials - Investing.com India
Compass Pathways to release new clinical data on psilocybin trials By Investing.com - Investing.com South Africa
What is Lifesci Capital’s Estimate for CMPS FY2025 Earnings? - Defense World
Compass Pathways Plc receives Investment Bank Analyst Rating Update By Investing.com - Investing.com
COMPASS Pathways Plc ADR (CMPS) Price Forecast: Bullish Reversal Gains Structure - FXEmpire
COMPASS Pathways plc's (NASDAQ:CMPS) institutional investors lost 16% over the past week but have profited from longer-term gains - Sahm
COMPASS Pathways (NASDAQ:CMPS) Stock Price Down 7.6%Should You Sell? - MarketBeat
Green Plains, Inc. (NASDAQ:GPRE) Given Average Rating of “Hold” by Analysts - Defense World
Nuclear Stocks To Watch Today – January 22nd - Defense World
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Expand Energy Corporation (NASDAQ:EXE) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Finanzdaten der Compass Pathways Plc Adr-Aktie (CMPS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.67%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):